Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy.
- Resource Type
- Article
- Source
- ACS Omega; 2/28/2019, Vol. 4 Issue 2, p4276-4295, 20p
- Subject
- Language
- ISSN
- 24701343